Literature DB >> 18989400

Orthotopic mouse model of colorectal cancer.

William Tseng1, Xianne Leong, Edgar Engleman.   

Abstract

The traditional subcutaneous tumor model is less than ideal for studying colorectal cancer. Orthotopic mouse models of colorectal cancer, which feature cancer cells growing in their natural location, replicate human disease with high fidelity. Two techniques can be used to establish this model. Both techniques are similar and require mouse anesthesia and laparotomy for exposure of the cecum. One technique involves injection of a colorectal cancer cell suspension into the cecal wall. Cancer cells are first grown in culture, harvested when subconfluent and prepared as a single cell suspension. A small volume of cells is injected slowly to avoid leakage. The other technique involves transplantation of a piece of subcutaneous tumor onto the cecum. A mouse with a previously established subcutaneous colorectal tumor is euthanized and the tumor is removed using sterile technique. The tumor piece is divided into small pieces for transplantation to another mouse. Prior to transplantation, the cecal wall is lightly damaged to facilitate tumor cell infiltration. The time to developing primary tumors and liver metastases will vary depending on the technique, cell line, and mouse species used. This orthotopic mouse model is useful for studying the natural progression of colorectal cancer and testing new therapeutic agents against colorectal cancer.

Entities:  

Mesh:

Year:  2007        PMID: 18989400      PMCID: PMC2557075          DOI: 10.3791/484

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  4 in total

Review 1.  Mouse models of colorectal cancer and liver metastases.

Authors:  M W Heijstek; O Kranenburg; I H M Borel Rinkes
Journal:  Dig Surg       Date:  2005-04-14       Impact factor: 2.588

Review 2.  Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans.

Authors:  M Kobaek-Larsen; I Thorup; A Diederichsen; C Fenger; M R Hoitinga
Journal:  Comp Med       Date:  2000-02       Impact factor: 0.982

3.  Intra-rectal injection of tumour cells: a novel animal model of rectal cancer.

Authors:  H Kashtan; M Rabau; J B Mullen; A H Wong; J C Roder; B Shpitz; H S Stern; S Gallinger
Journal:  Surg Oncol       Date:  1992-06       Impact factor: 3.279

4.  Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil.

Authors:  C Wilmanns; D Fan; C A O'Brian; C D Bucana; I J Fidler
Journal:  Int J Cancer       Date:  1992-08-19       Impact factor: 7.396

  4 in total
  51 in total

Review 1.  Immune cell interplay in colorectal cancer prognosis.

Authors:  Samuel E Norton; Kirsten A Ward-Hartstonge; Edward S Taylor; Roslyn A Kemp
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

2.  Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal Cancer Models through Distinct Mechanistic and Pharmacologic Properties.

Authors:  William H Gmeiner; Anthony Dominijanni; Alex O Haber; Lais P Ghiraldeli; David L Caudell; Ralph D'Agostino; Boris C Pasche; Thomas L Smith; Zhiyong Deng; Sezgin Kiren; Chinnadurai Mani; Komaraiah Palle; Jonathan R Brody
Journal:  Mol Cancer Ther       Date:  2020-12-23       Impact factor: 6.261

3.  Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse model.

Authors:  Hyunki Kim; Sharon Samuel; John W Totenhagen; Marie Warren; Jeffrey C Sellers; Donald J Buchsbaum
Journal:  J Vis Exp       Date:  2015-04-18       Impact factor: 1.355

4.  Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.

Authors:  Sara Rapic; Christel Vangestel; Jeroen Verhaeghe; Tim Van den Wyngaert; Rukun Hinz; Marleen Verhoye; Patrick Pauwels; Steven Staelens; Sigrid Stroobants
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

5.  Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones.

Authors:  Go Oshima; Melinda E Stack; Sean C Wightman; Darren Bryan; Elizabeth Poli; Lai Xue; Kinga B Skowron; Abhineet Uppal; Sean P Pitroda; Xiaona Huang; Mitchell C Posner; Samuel Hellman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

6.  Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling.

Authors:  Hong Jiang; Lisha Wu; Jing Chen; Murli Mishra; Hedy A Chawsheen; Haining Zhu; Qiou Wei
Journal:  Mol Cancer Res       Date:  2015-08-19       Impact factor: 5.852

7.  Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies.

Authors:  Zhen Lu; Angelica Ortiz; Ioannis I Verginadis; Amy R Peck; Farima Zahedi; Christina Cho; Pengfei Yu; Rachel M DeRita; Hongru Zhang; Ryan Kubanoff; Yunguang Sun; Andrew T Yaspan; Elise Krespan; Daniel P Beiting; Enrico Radaelli; Sandra W Ryeom; J Alan Diehl; Hallgeir Rui; Constantinos Koumenis; Serge Y Fuchs
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

8.  Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.

Authors:  Martin C Boonstra; Berend Tolner; Boudewijn E Schaafsma; Leonora S F Boogerd; Hendrica A J M Prevoo; Guarav Bhavsar; Peter J K Kuppen; Cornelis F M Sier; Bert A Bonsing; John V Frangioni; Cornelis J H van de Velde; Kerry A Chester; Alexander L Vahrmeijer
Journal:  Int J Cancer       Date:  2015-06-22       Impact factor: 7.396

9.  Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267.

Authors:  Jessica Kalra; Malathi Anantha; Corinna Warburton; Dawn Waterhouse; Hong Yan; Young-Joo Yang; Dita Strut; Maryam Osooly; Dana Masin; Marcel B Bally
Journal:  Cancer Biol Ther       Date:  2011-05-01       Impact factor: 4.742

10.  FOXC2 promotes colorectal cancer metastasis by directly targeting MET.

Authors:  Y-M Cui; H-L Jiao; Y-P Ye; C-M Chen; J-X Wang; N Tang; T-T Li; J Lin; L Qi; P Wu; S-Y Wang; M-R He; L Liang; X-W Bian; W-T Liao; Y-Q Ding
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.